Fig. 7.
Effect of EA on SBP was evaluated for two months during the follow-up study in 14 patients. Peak and average SBPs were reduced for one-month following the EA (PC5-6 + ST36-37) therapy. Peak and average SBPs were reduced at weeks six and eight during EA treatment. Significant decrease in SBP is indicated with (*)[45]. w, week(s).